Table 2. Relationship between p62 and LC3B expression and clinicopathologic variables in OSCCs.
| |
|
p62 in cytoplasm |
|
p62 in nucleus |
|
LC3B |
|
|||
|---|---|---|---|---|---|---|---|---|---|---|
| Variable | No. of cases | Low | High | P-value | Low | High | P-value | Low | High | P-value |
|
Age | ||||||||||
| ⩽50 Years | 71 | 38 | 33 | 0.882 | 41 | 30 | 0.243 | 39 | 32 | 0.735 |
| >50 Years |
124 |
65 |
59 |
|
82 |
42 |
|
65 |
59 |
|
|
Sex | ||||||||||
| Male | 187 | 97 | 90 | 0.285a | 118 | 69 | 1.000a | 97 | 90 | 0.001a* |
| Female |
8 |
6 |
2 |
|
5 |
3 |
|
7 |
1 |
|
|
T stage | ||||||||||
| T1/T2 | 126 | 71 | 55 | 0.182 | 79 | 47 | 0.882 | 68 | 58 | 0.81 |
| T3/T4 |
69 |
32 |
37 |
|
44 |
25 |
|
36 |
33 |
|
|
N stage | ||||||||||
| N0 | 145 | 86 | 59 | 0.002* | 88 | 57 | 0.239 | 82 | 63 | 0.125 |
| N1/N2/N3 |
50 |
17 |
33 |
|
35 |
15 |
|
22 |
28 |
|
|
M stage | ||||||||||
| M0 | 192 | 103 | 89 | 0.103a | 120 | 72 | 0.298a | 102 | 90 | 1.000a |
| M1 |
3 |
0 |
3 |
|
3 |
0 |
|
2 |
1 |
|
|
Stage | ||||||||||
| I/II | 106 | 66 | 40 | 0.004* | 63 | 43 | 0.25 | 60 | 46 | 0.318 |
| III/IV |
89 |
37 |
52 |
|
60 |
29 |
|
44 |
45 |
|
|
Histologic grade | ||||||||||
| G1/G2 | 168 | 101 | 67 | <0.001* | 101 | 67 | 0.033* | 92 | 76 | 0.319 |
| G3 |
27 |
2 |
25 |
|
22 |
5 |
|
12 |
15 |
|
|
Lymphovascular invasion | ||||||||||
| Absent | 147 | 87 | 60 | 0.002* | 90 | 57 | 0.348 | 85 | 62 | 0.028* |
| Present |
48 |
16 |
32 |
|
33 |
15 |
|
19 |
29 |
|
|
Necrosis | ||||||||||
| Limited/no | 145 | 86 | 59 | 0.002* | 89 | 56 | 0.403 | 82 | 63 | 0.125 |
| Extensive | 50 | 17 | 33 | 34 | 16 | 22 | 28 | |||
Abbreviation: OSCC=oral squamous cell carcinoma.
*P<0.05.
Fisher exact test.